Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIC: Mitomycin C vs Gemcitabine in NMIBC
NCT02695771Phase 3Completed
- Sponsor
- Corewell Health
- Start
- Apr 2016
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c, gemcitabine in non-muscle-invasive bladder cancer (NMIBC), sponsored by Corewell Health. Started Apr 2016; status: completed.
02
Drugs
mitomycin cgemcitabine
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT02695771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695771.